KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Free Cash Flow (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Free Cash Flow data on record, last reported at $108.5 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 5.46% year-over-year to $108.5 million; the TTM value through Dec 2025 reached $269.9 million, up 11.0%, while the annual FY2025 figure was $269.9 million, 11.0% up from the prior year.
  • Free Cash Flow reached $108.5 million in Q4 2025 per AMRX's latest filing, up from $106.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $136.4 million in Q1 2021 and bottomed at -$130.6 million in Q2 2022.
  • Average Free Cash Flow over 5 years is $51.4 million, with a median of $70.7 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: tumbled 175.95% in 2022, then soared 462.39% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $45.8 million in 2021, then crashed by 175.95% to -$34.8 million in 2022, then skyrocketed by 462.39% to $126.0 million in 2023, then fell by 18.29% to $102.9 million in 2024, then rose by 5.46% to $108.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $108.5 million in Q4 2025, $106.2 million in Q3 2025, and $61.0 million in Q2 2025.